A malignant tumor of the lungs; often linked to genetic damage from smoking or toxins.
Bloomberg reports a telehealth company has disclosed plans to sell already allowed compounds such as sermorelin and glutathione, which patients pursue for wellness benefits despite limited clinical evidence. The move underscores ongoing tensions between patient demand and scientific validation.
A wave of studies finds that AI analysis of mammograms can identify cardiovascular risks in women, including hypertension, coronary heart disease and stroke, alongside breast cancer screening. Researchers say mammograms could become a dual-purpose tool for early cardiovascular risk detection, prompting earlier intervention.
The experimental mRNA cancer vaccine, intismeran, has been tested in a phase 3 trial with 1,000+ melanoma patients. It is personalised to each patient by analysing tumors and targets neoantigens. When given with pembrolizumab, it aims to boost the immune response and extend cancer-free time. Results indicate reduced recurrence risk, but long-term survival remains to be seen. Trials also explore other cancers.
The FDA has approved daraxonrasib, sold as Rasonque by Revolution Medicines, for adults with previously treated or ineligible metastatic pancreatic cancer. Clinical trials have shown median survival extended to about 13.2 months versus roughly 6.7 months with chemotherapy. The drug will be available in the US with a roughly $39,800 monthly list price and expanded-access programmes have already treated thousands.
Investors have pushed new biotech winners — from Novo Nordisk’s semaglutide pill to startups tackling baldness and targeted autoimmune drugs — while market enthusiasm has cooled for some forecasts. Novo Nordisk has released a daily weight‑loss pill used by over 1.5 million people; hair‑loss startups have sent small caps soaring; India’s low‑cost GLP‑1 generics have underperformed expectations.
BBC presenter has polycythemia vera, an incurable yet manageable blood cancer diagnosed in 2024. She continues reporting while undergoing treatment and advocates awareness through Blood Cancer UK.
Three BBC investigations have revealed repeated failures in UK cancer care: a final review has found harm from misdiagnosis and inappropriate treatment by former Belfast neurologist Michael Watt; Coventry patients were prescribed temozolomide for years with little evidence of benefit; and England is missing cancer-treatment targets, with only 69.9% starting within 62 days. Officials and families are demanding answers.
Emma Bonino, longtime Italian politician and feminist activist, has died at 78, according to +Europa. Her career spanned over five decades, including roles as European commissioner and foreign minister. Tributes highlight her lifelong advocacy for abortion rights, humanitarian aid, migrants’ rights, and civil liberties across Italy and the EU.
Dame Esther Rantzen has died at 86 after a long illness, her family has announced. The broadcaster fronted That’s Life! for 21 years, founded Childline in 1986 and the Silver Line in 2012, and later campaigned publicly for legal change on assisted dying after a stage-four lung cancer diagnosis in 2023.
A new analysis shows a rise in cancers among people under 50 across England, the US and the Netherlands, driven by obesity, diet and lifestyle factors, with bowel, kidney and uterine cancers among the fastest-growing. Experts urge research and prevention as diagnosis at younger ages becomes more common.
Pope Leo XIV has undergone surgery at Rome's Gemelli Hospital to remove the lower lobe of his right lung after doctors found a small, localized nodule. Surgeons have confirmed lung adenocarcinoma; doctors have said postoperative blood tests and a chest X‑ray are within expected ranges and the pope has begun physiotherapy and walking in his room.
The pope has been discharged from Gemelli Hospital following a 90-minute operation to remove the lower lobe of his right lung after a lung nodule was diagnosed as adenocarcinoma. Doctors say he is recovering well and will continue his recovery ahead of a planned trip to Latin America in early November.
The Vatican has expressed grave concern over the humanitarian crisis in Oleshky, Kherson region, and has called for a ceasefire to allow food and medical aid delivery and civilian evacuation. The pope, recovering from lung surgery, is continuing to oversee efforts from Gemelli hospital, with potential plans to address the issue in the Angelus.
Pope Leo XIV has had the lower lung lobe removed and his recovery is progressing. Doctors say there is no clinical reason to stop the planned Nov. 6-17 trip to Uruguay, Argentina and Peru, though organizers are monitoring his health as he weighs travel amid ongoing treatment discussions.
Pope Leo has undergone lung surgery for adenocarcinoma. He has been discharged and is resuming duties while facing the possibility of adjusting his Latin America schedule, with no clinical reasons to cancel the trip. Tests to determine cancer spread are underway.
Pope Leo has had part of his lung removed and has begun to resume his schedule. He left Gemelli Hospital and is set to lead the Angelus from the Vatican window as doctors say he is fit for discharge. The Vatican confirms the operation was to remove a lower lobe and that the growth was detected at an early stage.
The pope has undergone a 90-minute lung-sparing operation for adenocarcinoma. Doctors say the procedure was successful and there were no complications; he remains in hospital as further tests determine additional treatment.
The Vatican reports that Pope Leo has resumed public duties after surgery to remove the lower lobe of his right lung. He has been diagnosed with lung adenocarcinoma. Officials caution that his schedule may be adjusted as he recovers, with a U.N. trip in November under consideration.
The Vatican has pressed for peace as Pope Leo has delivered a video message in Assisi, urging an end to war and a cease-fire in Ukraine. The pope’s humanitarian drive accelerates with a local cease-fire in Oleshky; a Vatican envoy leads aid shipments to Kyiv and other Ukrainian cities.
England launches STRIDE-RCT, a government-funded trial offering blood-based tests to 45-plus patients at about 200 GP surgeries to detect abdominal cancers early. The study will assess accuracy and determine if tests can guide urgent investigations for prostate, ovarian, bowel, pancreatic, stomach, liver and other cancers.
The Pope has arrived in Montevideo for the start of a 12-day Latin American tour that includes Uruguay, Argentina and Peru. He has confirmed his travel is proceeding despite surgery for a cancerous tumour and says universal healthcare should be accessible to all. He will meet leaders, attend masses, and visit communities amid regional challenges.